Therefore, we suggest that CO acts as a potent mediator of metabolic homeostasis by increasing endogenous FGF21 expression, which may have therapeutic implications in nonalcoholic steatohepatitis, obesity, type 2 diabetes, and related metabolic disorders. The gene discussed is FGF21; the disease is obesity disorder.